Clinical Trial

Magnetic Resonance Imaging of the Lung: Oncological Applications

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 20, 2026 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
Lung neoplasms are characterized by a complex interaction between tumor cells and a variety of resident and infiltrating host elements, secreted factors, and extracellular matrix proteins, collectively referred to as the microenvironment. Nowadays, in the setting of lung cancer, and in particular non-small cell lung cancer (NSCLC), the evaluation of microenvironment characteristics can only be performed by a pathologist and only on histological material. By combining different MRI parameters, it may be possible to create a specific imaging "signature" for the three different immune phenotypes and thus be able to make a distinction based on MRI examination.
Trial Details
NCT Number NCT07486219
Lead Sponsor Fondazione IRCCS Policlinico San Matteo di Pavia
Conditions Lung Cancer (NSCLC)
Enrollment 50 participants
Start Date 2020-01-15
Primary Completion 2026-04 (estimated)
Study Completion 2026-04 (estimated)
Updated on ClinicalTrials.gov 2026-03-20